Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9SGS

S315G KatG mutant no Heme

Summary for 9SGS
Entry DOI10.2210/pdb9sgs/pdb
Related9SGL 9SGM 9SGN 9SGO 9SGP 9SGQ 9SGR 9SGT 9SGY
EMDB information54879
DescriptorCatalase-peroxidase (1 entity in total)
Functional Keywordscatalase, peoxidase, enzyme, heme, metal binding protein
Biological sourceMycobacterium tuberculosis
Total number of polymer chains2
Total formula weight168078.41
Authors
Chaplin, A.K.,Allport, T. (deposition date: 2025-08-22, release date: 2026-01-14)
Primary citationAllport, T.,Chaplin, A.K.
Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo-EM.
Protein Sci., 35:e70409-e70409, 2026
Cited by
PubMed Abstract: Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is responsible for a global health burden affecting over a quarter of the world's population. The increasing prevalence of drug-resistant TB poses a significant threat to current treatment strategies. Isoniazid (INH) is a first-line prodrug used in TB therapy, which requires activation by the catalase-peroxidase enzyme KatG. Upon activation, INH inhibits InhA, thereby disrupting mycolic acid biosynthesis, a crucial process for maintaining Mtb's distinctive, lipid-rich cell wall. The most common naturally occurring resistance-associated mutation in KatG is S315T, though other variants at this position, such as S315G, S315N, S315I, and S315R, have also been reported. In this study, we employ cryo-electron microscopy (cryo-EM) to investigate the structural basis of INH resistance conferred by these KatG variants. We present high-resolution cryo-EM structures that reveal heterogeneity in heme loading among the mutants. Detailed structural analysis highlights alterations in the hydrogen-bonding network and substrate access channel unique to each variant, offering direct comparisons with the wild-type (WT) KatG protein. Our findings provide a molecular explanation for clinical INH resistance and lay the groundwork for the rational design of next-generation anti-TB therapeutics.
PubMed: 41432360
DOI: 10.1002/pro.70409
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.77 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon